OneWater Marine Sells Ocean Bio-Chem for $50M, Updates FY26 Guidance for Debt Reduction
ONEW sits 34% above its 52-week low of $10.14.
Summary
OneWater Marine Inc. announced the sale of Ocean Bio-Chem Holdings, Inc. for $50 million, using proceeds to reduce debt and updating its fiscal year 2026 guidance to reflect the strategic divestiture.
Key Events · M&A and Partnerships · ONEW
-
Strategic Divestiture Completed
OneWater Marine Inc. completed the sale of Ocean Bio-Chem Holdings, Inc. (OBCI) as part of a portfolio optimization strategy to focus on core assets.
-
$50 Million Proceeds for Debt Reduction
The company received $50 million from the sale, which will be used to reduce debt, aiming to bring net leverage below 4.0x by fiscal year-end and generate $3.5 million in annual interest expense savings.
-
Updated Fiscal Year 2026 Guidance
OneWater updated its full-year 2026 outlook, projecting total revenue of $1.78 billion to $1.88 billion, adjusted EBITDA of $60 million to $80 million, and adjusted diluted EPS of $0.20 to $0.70, reflecting the impact of the sale.
Analysis · ONEW · Trade & Services
OneWater Marine Inc. announced the strategic sale of Ocean Bio-Chem Holdings, Inc. for $50 million, a significant move to optimize its portfolio and focus on core assets. The proceeds will be used to reduce debt, which is expected to bring net leverage below 4.0x by fiscal year-end and generate approximately $3.5 million in annual interest expense savings. This divestiture leads to an updated fiscal full-year 2026 guidance, with total revenue now projected between $1.78 billion and $1.88 billion, adjusted EBITDA between $60 million and $80 million, and adjusted diluted EPS between $0.20 and $0.70. This proactive step aims to enhance financial flexibility and strengthen the balance sheet amidst a challenging industry outlook.
At the time of this filing, ONEW was trading at $13.58 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $223.8M. The 52-week trading range was $10.14 to $21.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.